 | • レポートコード：QYR2104Z4955 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、組換え抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（キメラ抗体、ヒト化抗体、完全ヒト抗体、一本鎖抗体、二重特異性抗体）、用途別市場規模（病院、科学研究、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・組換え抗体の市場動向 ・企業の競争状況、市場シェア ・組換え抗体の種類別市場規模（キメラ抗体、ヒト化抗体、完全ヒト抗体、一本鎖抗体、二重特異性抗体） ・組換え抗体の用途別市場規模（病院、科学研究、その他） ・組換え抗体の北米市場規模2016-2027（アメリカ、カナダ） ・組換え抗体のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・組換え抗体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・組換え抗体の中南米市場規模2016-2027（メキシコ、ブラジル） ・組換え抗体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abnova、Medix Biochemica、GE Healthcare、SinoBiological、Bioventix） ・結論 |
Market Analysis and Insights: Global Recombinant Antibody Market
The global Recombinant Antibody market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant Antibody market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant Antibody market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant Antibody market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant Antibody market.
Global Recombinant Antibody Scope and Market Size
Recombinant Antibody market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chimeric Antibody
Humanized Antibody
Full Human Antibody
Single Chain Antibody
Bispecific Antibody
Segment by Application
Hospital
Scientific Research
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abnova
Medix Biochemica
GE Healthcare
SinoBiological
Bioventix
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Antibody Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chimeric Antibody
1.2.3 Humanized Antibody
1.2.4 Full Human Antibody
1.2.5 Single Chain Antibody
1.2.6 Bispecific Antibody
1.3 Market by Application
1.3.1 Global Recombinant Antibody Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Antibody Market Perspective (2016-2027)
2.2 Recombinant Antibody Growth Trends by Regions
2.2.1 Recombinant Antibody Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Recombinant Antibody Historic Market Share by Regions (2016-2021)
2.2.3 Recombinant Antibody Forecasted Market Size by Regions (2022-2027)
2.3 Recombinant Antibody Industry Dynamic
2.3.1 Recombinant Antibody Market Trends
2.3.2 Recombinant Antibody Market Drivers
2.3.3 Recombinant Antibody Market Challenges
2.3.4 Recombinant Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Antibody Players by Revenue
3.1.1 Global Top Recombinant Antibody Players by Revenue (2016-2021)
3.1.2 Global Recombinant Antibody Revenue Market Share by Players (2016-2021)
3.2 Global Recombinant Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Recombinant Antibody Revenue
3.4 Global Recombinant Antibody Market Concentration Ratio
3.4.1 Global Recombinant Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Antibody Revenue in 2020
3.5 Recombinant Antibody Key Players Head office and Area Served
3.6 Key Players Recombinant Antibody Product Solution and Service
3.7 Date of Enter into Recombinant Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Antibody Breakdown Data by Type
4.1 Global Recombinant Antibody Historic Market Size by Type (2016-2021)
4.2 Global Recombinant Antibody Forecasted Market Size by Type (2022-2027)
5 Recombinant Antibody Breakdown Data by Application
5.1 Global Recombinant Antibody Historic Market Size by Application (2016-2021)
5.2 Global Recombinant Antibody Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Recombinant Antibody Market Size (2016-2027)
6.2 North America Recombinant Antibody Market Size by Type
6.2.1 North America Recombinant Antibody Market Size by Type (2016-2021)
6.2.2 North America Recombinant Antibody Market Size by Type (2022-2027)
6.2.3 North America Recombinant Antibody Market Size by Type (2016-2027)
6.3 North America Recombinant Antibody Market Size by Application
6.3.1 North America Recombinant Antibody Market Size by Application (2016-2021)
6.3.2 North America Recombinant Antibody Market Size by Application (2022-2027)
6.3.3 North America Recombinant Antibody Market Size by Application (2016-2027)
6.4 North America Recombinant Antibody Market Size by Country
6.4.1 North America Recombinant Antibody Market Size by Country (2016-2021)
6.4.2 North America Recombinant Antibody Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Recombinant Antibody Market Size (2016-2027)
7.2 Europe Recombinant Antibody Market Size by Type
7.2.1 Europe Recombinant Antibody Market Size by Type (2016-2021)
7.2.2 Europe Recombinant Antibody Market Size by Type (2022-2027)
7.2.3 Europe Recombinant Antibody Market Size by Type (2016-2027)
7.3 Europe Recombinant Antibody Market Size by Application
7.3.1 Europe Recombinant Antibody Market Size by Application (2016-2021)
7.3.2 Europe Recombinant Antibody Market Size by Application (2022-2027)
7.3.3 Europe Recombinant Antibody Market Size by Application (2016-2027)
7.4 Europe Recombinant Antibody Market Size by Country
7.4.1 Europe Recombinant Antibody Market Size by Country (2016-2021)
7.4.2 Europe Recombinant Antibody Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Antibody Market Size (2016-2027)
8.2 Asia-Pacific Recombinant Antibody Market Size by Type
8.2.1 Asia-Pacific Recombinant Antibody Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Recombinant Antibody Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Recombinant Antibody Market Size by Type (2016-2027)
8.3 Asia-Pacific Recombinant Antibody Market Size by Application
8.3.1 Asia-Pacific Recombinant Antibody Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Recombinant Antibody Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Recombinant Antibody Market Size by Application (2016-2027)
8.4 Asia-Pacific Recombinant Antibody Market Size by Region
8.4.1 Asia-Pacific Recombinant Antibody Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Recombinant Antibody Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Recombinant Antibody Market Size (2016-2027)
9.2 Latin America Recombinant Antibody Market Size by Type
9.2.1 Latin America Recombinant Antibody Market Size by Type (2016-2021)
9.2.2 Latin America Recombinant Antibody Market Size by Type (2022-2027)
9.2.3 Latin America Recombinant Antibody Market Size by Type (2016-2027)
9.3 Latin America Recombinant Antibody Market Size by Application
9.3.1 Latin America Recombinant Antibody Market Size by Application (2016-2021)
9.3.2 Latin America Recombinant Antibody Market Size by Application (2022-2027)
9.3.3 Latin America Recombinant Antibody Market Size by Application (2016-2027)
9.4 Latin America Recombinant Antibody Market Size by Country
9.4.1 Latin America Recombinant Antibody Market Size by Country (2016-2021)
9.4.2 Latin America Recombinant Antibody Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Antibody Market Size (2016-2027)
10.2 Middle East & Africa Recombinant Antibody Market Size by Type
10.2.1 Middle East & Africa Recombinant Antibody Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Recombinant Antibody Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Recombinant Antibody Market Size by Type (2016-2027)
10.3 Middle East & Africa Recombinant Antibody Market Size by Application
10.3.1 Middle East & Africa Recombinant Antibody Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Recombinant Antibody Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Recombinant Antibody Market Size by Application (2016-2027)
10.4 Middle East & Africa Recombinant Antibody Market Size by Country
10.4.1 Middle East & Africa Recombinant Antibody Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Recombinant Antibody Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abnova
11.1.1 Abnova Company Details
11.1.2 Abnova Business Overview
11.1.3 Abnova Recombinant Antibody Introduction
11.1.4 Abnova Revenue in Recombinant Antibody Business (2016-2021)
11.1.5 Abnova Recent Development
11.2 Medix Biochemica
11.2.1 Medix Biochemica Company Details
11.2.2 Medix Biochemica Business Overview
11.2.3 Medix Biochemica Recombinant Antibody Introduction
11.2.4 Medix Biochemica Revenue in Recombinant Antibody Business (2016-2021)
11.2.5 Medix Biochemica Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Recombinant Antibody Introduction
11.3.4 GE Healthcare Revenue in Recombinant Antibody Business (2016-2021)
11.3.5 GE Healthcare Recent Development
11.4 SinoBiological
11.4.1 SinoBiological Company Details
11.4.2 SinoBiological Business Overview
11.4.3 SinoBiological Recombinant Antibody Introduction
11.4.4 SinoBiological Revenue in Recombinant Antibody Business (2016-2021)
11.4.5 SinoBiological Recent Development
11.5 Bioventix
11.5.1 Bioventix Company Details
11.5.2 Bioventix Business Overview
11.5.3 Bioventix Recombinant Antibody Introduction
11.5.4 Bioventix Revenue in Recombinant Antibody Business (2016-2021)
11.5.5 Bioventix Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Recombinant Antibody Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chimeric Antibody
Table 3. Key Players of Humanized Antibody
Table 4. Key Players of Full Human Antibody
Table 5. Key Players of Single Chain Antibody
Table 6. Key Players of Bispecific Antibody
Table 7. Global Recombinant Antibody Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Recombinant Antibody Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Recombinant Antibody Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Recombinant Antibody Market Share by Regions (2016-2021)
Table 11. Global Recombinant Antibody Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Recombinant Antibody Market Share by Regions (2022-2027)
Table 13. Recombinant Antibody Market Trends
Table 14. Recombinant Antibody Market Drivers
Table 15. Recombinant Antibody Market Challenges
Table 16. Recombinant Antibody Market Restraints
Table 17. Global Recombinant Antibody Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Recombinant Antibody Market Share by Players (2016-2021)
Table 19. Global Top Recombinant Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Antibody as of 2020)
Table 20. Ranking of Global Top Recombinant Antibody Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Recombinant Antibody Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Recombinant Antibody Product Solution and Service
Table 24. Date of Enter into Recombinant Antibody Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Recombinant Antibody Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Recombinant Antibody Revenue Market Share by Type (2016-2021)
Table 28. Global Recombinant Antibody Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Recombinant Antibody Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Recombinant Antibody Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Recombinant Antibody Revenue Market Share by Application (2016-2021)
Table 32. Global Recombinant Antibody Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Recombinant Antibody Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Recombinant Antibody Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Recombinant Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Recombinant Antibody Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Recombinant Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Recombinant Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Recombinant Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Recombinant Antibody Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Recombinant Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Recombinant Antibody Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Recombinant Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Recombinant Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Recombinant Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Recombinant Antibody Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Recombinant Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Recombinant Antibody Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Recombinant Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Recombinant Antibody Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Recombinant Antibody Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Recombinant Antibody Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Recombinant Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Recombinant Antibody Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Recombinant Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Recombinant Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Recombinant Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Recombinant Antibody Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Recombinant Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Recombinant Antibody Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Recombinant Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Recombinant Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Recombinant Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abnova Company Details
Table 65. Abnova Business Overview
Table 66. Abnova Recombinant Antibody Product
Table 67. Abnova Revenue in Recombinant Antibody Business (2016-2021) & (US$ Million)
Table 68. Abnova Recent Development
Table 69. Medix Biochemica Company Details
Table 70. Medix Biochemica Business Overview
Table 71. Medix Biochemica Recombinant Antibody Product
Table 72. Medix Biochemica Revenue in Recombinant Antibody Business (2016-2021) & (US$ Million)
Table 73. Medix Biochemica Recent Development
Table 74. GE Healthcare Company Details
Table 75. GE Healthcare Business Overview
Table 76. GE Healthcare Recombinant Antibody Product
Table 77. GE Healthcare Revenue in Recombinant Antibody Business (2016-2021) & (US$ Million)
Table 78. GE Healthcare Recent Development
Table 79. SinoBiological Company Details
Table 80. SinoBiological Business Overview
Table 81. SinoBiological Recombinant Antibody Product
Table 82. SinoBiological Revenue in Recombinant Antibody Business (2016-2021) & (US$ Million)
Table 83. SinoBiological Recent Development
Table 84. Bioventix Company Details
Table 85. Bioventix Business Overview
Table 86. Bioventix Recombinant Antibody Product
Table 87. Bioventix Revenue in Recombinant Antibody Business (2016-2021) & (US$ Million)
Table 88. Bioventix Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant Antibody Market Share by Type: 2020 VS 2027
Figure 2. Chimeric Antibody Features
Figure 3. Humanized Antibody Features
Figure 4. Full Human Antibody Features
Figure 5. Single Chain Antibody Features
Figure 6. Bispecific Antibody Features
Figure 7. Global Recombinant Antibody Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Scientific Research Case Studies
Figure 10. Others Case Studies
Figure 11. Recombinant Antibody Report Years Considered
Figure 12. Global Recombinant Antibody Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Recombinant Antibody Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Recombinant Antibody Market Share by Regions: 2020 VS 2027
Figure 15. Global Recombinant Antibody Market Share by Regions (2022-2027)
Figure 16. Global Recombinant Antibody Market Share by Players in 2020
Figure 17. Global Top Recombinant Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Antibody as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Recombinant Antibody Revenue in 2020
Figure 19. Global Recombinant Antibody Revenue Market Share by Type (2016-2021)
Figure 20. Global Recombinant Antibody Revenue Market Share by Type (2022-2027)
Figure 21. North America Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Recombinant Antibody Market Share by Type (2016-2027)
Figure 23. North America Recombinant Antibody Market Share by Application (2016-2027)
Figure 24. North America Recombinant Antibody Market Share by Country (2016-2027)
Figure 25. United States Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Recombinant Antibody Market Share by Type (2016-2027)
Figure 29. Europe Recombinant Antibody Market Share by Application (2016-2027)
Figure 30. Europe Recombinant Antibody Market Share by Country (2016-2027)
Figure 31. Germany Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Recombinant Antibody Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Recombinant Antibody Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Recombinant Antibody Market Share by Region (2016-2027)
Figure 41. China Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Recombinant Antibody Market Share by Type (2016-2027)
Figure 49. Latin America Recombinant Antibody Market Share by Application (2016-2027)
Figure 50. Latin America Recombinant Antibody Market Share by Country (2016-2027)
Figure 51. Mexico Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Recombinant Antibody Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Recombinant Antibody Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Recombinant Antibody Market Share by Country (2016-2027)
Figure 57. Turkey Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Recombinant Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abnova Revenue Growth Rate in Recombinant Antibody Business (2016-2021)
Figure 61. Medix Biochemica Revenue Growth Rate in Recombinant Antibody Business (2016-2021)
Figure 62. GE Healthcare Revenue Growth Rate in Recombinant Antibody Business (2016-2021)
Figure 63. SinoBiological Revenue Growth Rate in Recombinant Antibody Business (2016-2021)
Figure 64. Bioventix Revenue Growth Rate in Recombinant Antibody Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界のヒト化抗体市場規模・現状・予測（2021年-2027年） Humanized antibodies mainly refer to antibodies re-expressed by gene cloning and DNA recombination technology of mouse monoclonal antibodies, most of the amino acid sequences of which are replaced by human sequences, and reducing the Its heterogeneity is beneficial to the human body.The constant reg…- 世界の二重特異性抗体医薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bispecific Antibody Drug Market The global Bispecific Antibody Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の二重特異性抗体医薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bispecific Antibody Drug Market The global Bispecific Antibody Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界のモノクローナル抗体療法市場規模・現状・予測（2021年-2027年） Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal ant…
- 世界のHS3S4抗体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global HS3S4 Antibody Market The global HS3S4 Antibody market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brill…